MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.opresp.2026.100669

Медицинская библиотека · Open respiratory archives · 2026

Prevalence and Maintenance of Clinical Remission in Patients with Severe Uncontrolled Asthma Undergoing Biologic Therapies.

Dorado-Fonseca Elena, García de Pedro Julia, Ji Zichen, Recio-Moreno Beatriz, de Miguel-Rodríguez Laura, Buendía-García María Jesús, de Miguel-Díez Javier

СтатьяПеревод пока не подготовлен

Аннотация

Clinical remission is an emerging treatment goal in severe asthma, although real-world data on its long-term maintenance remain limited. We retrospectively evaluated 50 patients who initiated first-line biologic therapy with omalizumab, mepolizumab, or reslizumab between 2015 and 2019. Clinical remission at 12 months was defined as no moderate or severe exacerbations, an asthma control test (ACT) score of ≥20, post-bronchodilator forced expiratory volume in 1 second of ≥80% predicted, and no use of maintenance oral corticosteroid. Of these patients, 13 (26.0%) met the criteria for remission. They had significantly higher unadjusted baseline forced vital capacities (FVC; 103.6% vs. 85.7%, p = 0.002) and ACT scores (17.5 vs. 11.0, p < 0.001), and 6 (46.2%) maintained remission over a median follow-up of 63.0 months. Although remission was achieved in approximately one-quarter of patients, it was maintained in fewer than half. Our baseline FVC and ACT findings require confirmation in larger studies.

Для цитирования: Dorado-Fonseca Elena, García de Pedro Julia, Ji Zichen, Recio-Moreno Beatriz, de Miguel-Rodríguez Laura, Buendía-García María Jesús, de Miguel-Díez Javier. Prevalence and Maintenance of Clinical Remission in Patients with Severe Uncontrolled Asthma Undergoing Biologic Therapies.. Open respiratory archives. 2026. DOI: 10.1016/j.opresp.2026.100669.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.